SCHEMBL23701385

SCHEMBL23701385

CCNC(=O)N1C[C@@]2(C)CN(c3ccc(N4CCS(O)(O)CC4)cc3)C[C@@]2(C)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
HTT P42858 2/20 0.39
HDAC3 O15379 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
KDM4E B2RXH2 3/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
POLB P06746 2/20 0.35
ALK Q9UM73 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
EPHX2 P34913 1/20 0.34
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
CTSS P25774 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23701387 0.91 ALDH1A1 (0.47) KMT2AALDH1A1MAPTHTTHDAC3
SCHEMBL23701390 0.91 ALDH1A1 (0.47) KMT2AALDH1A1MAPTHTTHDAC3
SCHEMBL27400024 0.84 KMT2A (0.41) KMT2AALDH1A1MAPTHTTKDM4E
SCHEMBL23701434 0.83 KDM4E (0.41) KMT2AALDH1A1HTTKDM4ESMN1; SMN2
SCHEMBL23701454 0.82 TSHR (0.45) KMT2AALDH1A1MAPTHTTKDM4E
SCHEMBL23701456 0.82 TSHR (0.45) KMT2AALDH1A1MAPTHTTKDM4E
SCHEMBL23701395 0.82 GAA (0.50) KMT2AALDH1A1MAPTHTTKDM4E
SCHEMBL23701397 0.82 GAA (0.50) KMT2AALDH1A1MAPTHTTKDM4E
SCHEMBL27400160 0.82 ALDH1A1 (0.45) KMT2AALDH1A1MAPTHDAC3HDAC8
SCHEMBL23701399 0.80 ALDH1A1 (0.45) KMT2AALDH1A1KDM4EMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018029-B2 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2024-06-25 US disclosed
US-20210238179-A1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018029-B2 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors LOX, LOXL1, LOXL3 KMT2A 3462/4885ALDH1A1 765/4885MAPT 4829/4885
US-20210238179-A1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS LOX, LOXL1, LOXL3 KMT2A 3462/4885ALDH1A1 765/4885MAPT 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.